Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 4/20 | 0.38 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.31 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13676391 | 0.80 | DPP4 (0.38) | DPP4DYRK1ADPP8 | |
| SCHEMBL24463371 | 0.80 | DPP4 (0.35) | DPP4DYRK1ADPP8 | |
| SCHEMBL29669299 | 0.80 | DPP4 (0.35) | DPP4DYRK1ADPP8 | |
| SCHEMBL24463239 | 0.77 | DPP4 (0.37) | DPP4DYRK1ADPP8 | |
| SCHEMBL30390911 | 0.77 | DPP4 (0.37) | DPP4DYRK1ADPP8 | |
| SCHEMBL24463625 | 0.76 | DPP4 (0.38) | DPP4DYRK1ADPP8 | |
| SCHEMBL30263630 | 0.76 | DPP4 (0.36) | DPP4 | |
| SCHEMBL24463286 | 0.76 | — | — | |
| SCHEMBL17563255 | 0.74 | DPP4 (0.36) | DPP4DPP8 | |
| SCHEMBL20512424 | 0.73 | DPP4 (0.42) | DPP4DPP8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116057045-A | Fibroblast growth factor receptor kinase inhibitors | 金耐特生物制药公司 | 2023-05-02 | — | — | CN | disclosed |
| EP-4161656-A1 | INHIBITORS OF FIBROBLAST GROWTH FACTOR RECEPTOR KINASES | Kinnate Biopharma Inc. (US) | 2023-04-12 | — | — | EP | disclosed |
| US-11345681-B1 | Inhibitors of fibroblast growth factor receptor kinases | KINNATE BIOPHARMA INC. (US) | 2022-05-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11345681-B1 | Inhibitors of fibroblast growth factor receptor kinases | FGFR1, FGFR2, FGFR3 | DPP4 2192/4885DYRK1A 967/4885DPP8 1200/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.